| 21 |
|
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage/
|
Soejima, K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 22 |
|
Additional alpha applications/
|
Scheinberg, D. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 23 |
|
Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells/
|
Panther, E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 24 |
|
Adhesion of normal and Plasmodium falciparum ring-infected erythrocytes to endothelial cells and the placenta involves the rhoptry-derived ring surface protein-2/
|
Douki, J.-B. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 25 |
|
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34^+-selected hematopoietic cell transplantation/
|
Laport, G. G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 26 |
|
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma/
|
Hamlin, P. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 27 |
|
Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice/
|
Levi, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 28 |
|
Agranulocytosis unresponsive to growth factors following rituximab in vivo purging/
|
Rose, A. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 29 |
|
AIDS lymphomas: beginning of an EPOCH?/
|
Scadden, D. T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 30 |
|
Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells/
|
Wang, X
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 31 |
|
ALG/ATG: illuminating the occult/
|
Steensma, D. P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 32 |
|
ALK in NHL: To B (cell) or not to B (cell)? Characterization of the entity "ALK^+ DLBCL"/
|
Morris, S. W
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 33 |
|
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases/
|
Gascoyne, R. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 34 |
|
Allogeneic hematopoietic stem cell transplantation for myelofibrosis/
|
Deeg, H. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 35 |
|
Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever/
|
Touitou, I
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 36 |
|
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma/
|
Maloney, D. G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 37 |
|
alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry/
|
Weigel-Kelley, K. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 38 |
|
Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val/
|
Doggett, T. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 39 |
|
Alternative 5' exons and differential splicing regulate expression of protein 4.1R isoforms with distinct N-termini/
|
Parra, M. K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 40 |
|
AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma/
|
Choi, S. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
기사
(79)
